Published in
Elsevier, The Lancet, 10292(397), p. 2361-2371, 2021
DOI: 10.1016/s0140-6736(21)00592-4
Links
Tools
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Journal article published in 2021 by
Philippe Moreau,
Meletios-Athanasios Dimopoulos,
Joseph Mikhael,
Kwee Yong,
Marcelo Capra,
Thierry Facon,
Roman Hajek,
Ivan Špička,
Ross Baker 
,
Kihyun Kim,
Gracia Martinez,
Chang-Ki Min,
Ludek Pour,
Xavier Leleu,
Albert Oriol
and other authors.
,
Kihyun Kim,
Gracia Martinez,
Chang-Ki Min,
Ludek Pour,
Xavier Leleu,
Albert Oriol
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 